FeLV in Iberian lynxes: surveillance from 2008 to 2021 and limits of the evidence

Scientific reports · 2024

In plain language

In Iberian lynxes surveyed from 2008 to 2021, viral DNA integrated into cells was detected more often than the viral protein p27, but the tests involved groups of different sizes. Deaths from bone marrow failure and one from squamous cell carcinoma were documented, without establishing that FeLV caused that cancer. The authors suggest that lynxes might control infection in some tissues, but they did not demonstrate how. These findings cannot be applied directly to domestic cats and do not establish cancer prevention.

Scientific detail

This observational study, published in Scientific Reports in 2024, describes FeLV surveillance in Iberian lynxes (Lynx pardinus) in Andalusia during 2008–2021. The Methods section reports 776 records from 586 lynxes, including 422 clinical evaluations and 353 necropsies; 129 lynxes were sampled longitudinally, generating 329 records. Assay-specific denominators were 360 individuals for p27 ELISA, 503 for blood proviral DNA, and 333 for tissue proviral DNA. An additional 81 sympatric domestic cats were sampled. Limited blood quantities or tissue preservation prevented every test from being performed on every individual.

FeLV proviral DNA was detected more frequently than p27 antigen. These are assay-specific prevalence estimates with different denominators, not a controlled comparison of diagnostic sensitivity. Proviral detection alone does not establish progressive disease or neoplasia; proviral PCR without quantified loads also has limitations in determining disease stage. The authors suggest that lynxes may control infection within bone marrow and other lymphoid tissues. This is a tentative interpretation, not an experimentally demonstrated mechanism, and neither viral strain nor infectious dose was investigated.

Among FeLV provirus-positive lynxes followed from the 2007 outbreak, reported causes of death included squamous cell carcinoma, although most deaths were attributed to bone marrow aplasia. The study does not establish that FeLV caused the carcinoma, demonstrate viral integration in that tumor, or provide a controlled comparison of cancer risk. In the reported fatal clinical case, the antigenemic lynx had severe bone marrow aplasia, Streptococcus septicemia, and renal and splenic necrosis at necropsy. This case documents marrow failure and concurrent septicemia, not a diagnosis of leukemia or lymphoma, and cannot isolate the causal contribution of each finding.

All four claims carry evidence level D; for the detection comparison, this level reflects the cap applied because the species is not the domestic cat. The findings are direct evidence for the lynxes studied, but their application to domestic cats is indirect. They establish neither a mechanism of FeLV-induced oncogenesis nor prevention of lymphoma, leukemia, or other malignancies. Lymphoma or leukemia incidence and tumor-specific proviral integration analyses are not reported.

What we know

The surveillance documents FeLV infection and associated hematological disease in Iberian lynxes. Proviral DNA was detected more frequently than p27, with different denominators for each assay. Deaths attributed to bone marrow aplasia and one to squamous cell carcinoma were recorded; the reported fatal clinical case also involved Streptococcus septicemia and renal and splenic necrosis. These are level D observational findings with indirect application to domestic cats.

What we don't know

The infection-control mechanism proposed by the authors has not been demonstrated. Viral strain and infectious dose were not investigated, and proviral PCR without quantified loads limits determination of disease stage. Neither FeLV causation of the carcinoma nor the causal contribution of each finding in the fatal case is established. Lymphoma or leukemia incidence and tumor-specific proviral integration analyses are not reported, and there is no controlled comparison of cancer risk. These findings do not establish cancer prevention and cannot be generalized directly to domestic cats.

Evidence

Provenance

This project does not diagnose or prescribe. Always consult your veterinarian.